Walgreens Boots Alliance Appoints William H. Shrank, M.D., to Board of Directors
Walgreens Boots Alliance Appoints William H. Shrank, M.D., to Board of Directors
DEERFIELD, Ill. -- JULY 10, 2024 -- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of William H. Shrank, M.D., to the company's board of directors. Dr. Shrank is globally recognized for his leadership and expertise in healthcare strategy, policy and population health. He joins the WBA board at an important time as the company strengthens its business.
2024年7月10日，伊利諾伊州迪爾菲爾德——納斯達克(WBA)宣佈任命 William H. Shrank 博士爲公司董事會成員。Shrank博士以其在醫療保健策略、政策和人口健康領域的領導力和專業知識而全球知名。他加入WBA董事會的時機非常重要，因爲公司正在加強業務。
Currently, Dr. Shrank is a venture partner with the Bio + Health Team of Andreesen Horowitz, a private venture capital firm, a role he has held since January 2023. He previously served in a number of senior leadership roles with Fortune 50 companies including Chief Medical Officer (CMO) for Humana, Inc. and Chief Scientific Officer and CMO of Provider Innovation for CVS Health.
Shrank博士目前是安德烈森-霍洛維茨公司(Bio+Health團隊)的風險投資合夥人，此職務自2023年1月以來擔任。他此前曾在多家財富50強企業擔任高級領導職務，包括Humana公司的首席醫療官(CMO)、CVS Health公司的首席科學家兼CMO of Provider Innovation。
"Dr. Shrank is a strategic, experienced healthcare leader and I am proud to have him on our board as we execute the turnaround plan for our business," said Tim Wentworth, Walgreens Boots Alliance CEO. "As the healthcare and retail landscapes continue to evolve and we further enhance our focus and sharpen execution, I am confident that his background will help us elevate the value of community pharmacy and unlock opportunities for our long-term strategy."
"Shrank博士是一位有戰略眼光、經驗豐富的醫療保健領導者，我很自豪能讓他加入我們的董事會，因爲我們正在執行公司的重組計劃，"沃爾格林-聯合博姿(Walgreens Boots Alliance) CEO Tim Wentworth表示。"隨着醫療保健和零售格局的持續演變，我們進一步優化業務和提高執行力，我相信他的背景將有助於我們提高社區藥房的價值，爲我們的長期戰略創造機遇。"
"I am pleased to welcome Dr. Shrank to the WBA Board of Directors," said Stefano Pessina, Executive Chairman, Walgreens Boots Alliance. "I look forward to working with Dr. Shrank and know that his clinical and business insights, experience and patient-centric approach will be a strong asset for WBA driving long-term value for our patients, customers and shareholders."
"萬泰諾"(Stefano Pessina)，沃爾格林-聯合博姿執行董事長說:"我很高興歡迎Shrank博士加入WBA董事會。我期待與Shrank博士共事，我知道他的臨床和業務見解、經驗和以患者爲中心的方法將成爲WBA的重要資產，爲我們的患者、客戶和股東創造長期價值。"
Prior to joining Andreesen Horowitz, Dr. Shrank served as Chief Medical Officer of Humana Inc., a leading care delivery and health plan administration company, from April 2019 to August 2022. His responsibilities included implementing Humana's integrated care delivery strategy with an emphasis on advancing the company's clinical capabilities and improving the health outcomes of its members. He also led Humana's Care Delivery Organization, clinical operations and population health strategy.
在加入安德魯森-哈洛維茲之前，Shrank博士自2019年4月至2022年8月擔任美國一家領先的保健交付和醫療保險管理公司Humana Inc.的首席醫療官。他的職責包括實施Humana的綜合醫療交付策略，重點是推進公司的臨床能力並改善其成員的健康結果。他還領導了Humana的醫療服務組織、臨床運營和人口健康策略。
Previously, Dr. Shrank served as Chief Medical Officer, Insurance Services Division, of the University of Pittsburgh Medical Center (UPMC) from April 2016 to February 2019. From 2013 to 2016, Dr. Shrank held several leadership positions with CVS Health Corporation, including Senior Vice President, Chief Scientific Officer, and Chief Medical Officer of Provider Innovation. He also worked for the Center for Medicare and Medicaid Innovation, part of the Centers for Medicare and Medicaid Services (CMS), as Director, Research and Rapid-Cycle Evaluation Group.
此前，Shrank博士自2016年4月至2019年2月擔任醫療保險服務部門的首席醫療官，該部門隸屬於匹茲堡大學醫學中心(UPMC)。從2013年到2016年，Shrank博士曾擔任CVS Health Corporation的多個領導職務，包括提供商創新的高級副主席、首席科學家和首席醫療官。他還曾擔任醫療保險與醫療補助服務中心(CMS)的醫療保健創新與評估研究小組主任。
Dr. Shrank began his career as a practicing physician with Brigham and Women's Hospital in Boston, Mass. and as an assistant professor at Harvard Medical School. He received his B.A. in Psychology from Brown University and an M.D. from Cornell University Medical College. He also holds an M.S. in Health Services from the University of California, Los Angeles.
Shrank博士的職業生涯始於波士頓的布里格姆婦女醫院和哈佛醫學院助理教授。他獲得布朗大學心理學學士學位和康奈爾大學醫學院醫學博士學位。他還獲得加利福尼亞大學洛杉磯分校的健康服務碩士學位。
"I have seen firsthand the trust and relationship patients have with their pharmacist and the critical role pharmacies serve as the front door to the healthcare system in most communities," said Dr. Shrank. "Walgreens and Boots are trusted brands, and I'm honored to have the opportunity to work with leadership and the WBA Board of Directors to advance the company's vision and strategy to transform healthcare delivery."
"我親眼見識了患者與藥劑師之間的信任和關係，以及藥房在大多數社區成爲醫療系統門面的至關重要的作用，" Shrank博士說:"沃爾格林(Walgreens)和博姿(Boots)是信任的品牌，我很榮幸有機會與領導層和WBA董事會合作，推動公司的願景和戰略，改變醫療保健交付。"
Earlier this year, WBA announced several new executive appointments to deepen the company's healthcare expertise and position company for accelerated growth.
今年早些時候，WBA宣佈了幾項新的高管任命，以加深公司的醫療保健專業知識，爲公司的加速增長做好準備。
About Walgreens Boots Alliance
關於沃爾格林-聯合博姿
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovator in retail pharmacy with approximately 12,500 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem. The Company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high quality health and beauty products and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.
沃爾格林-聯合博姿(Walgreens Boots Alliance，納斯達克代碼：WBA)是一家綜合醫療保健、藥房和零售領導者，每天爲數百萬客戶和患者服務，擁有170年的社區護理傳統。作爲零售藥房領域的信任全球創新者，WBA在美國、歐洲和拉丁美洲擁有約12,500個門店，在醫療保健生態系統中發揮着至關重要的作用。該公司在其目的的指導下重新設想了包括所有人在內的當地醫療保健與福祉的做法，以創造更快樂的生活。通過發藥、提高各種健康服務的接入性、提供高質量的健康與美容產品以及通過數字平台提供隨時隨地的便利服務，WBA塑造了醫療保健的未來。
WBA employs more than 330,000 people and has a presence in eight countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico. Additionally, WBA has a portfolio of healthcare-focused investments located in several countries, including China and the U.S.
WBA擁有330,000多名員工，並通過其消費品牌在8個國家開展業務：Walgreens、Boots、Duane Reade、No7 Beauty Company和墨西哥的Benavides。此外，WBA在多個國家還擁有一系列以醫療保健爲重點的投資項目，包括中國和美國。
The Company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA has been recognized for its commitment to operating sustainably: the Company is an index component of the Dow Jones Sustainability Indices (DJSI) and was named to the 100 Best Corporate Citizens 2022.
該公司爲健康社區、健康星球、一個包容性的工作場所和一個可持續的市場的貢獻感到自豪。沃爾格林-聯合博姿的可持續運營承諾備受認可：該公司是道瓊斯可持續發展指數（DJSI）的指數組成部分，併入選了2022年最佳企業公民100強。
More Company information is available at .
更多公司信息可以在此網址獲得。
WBA Media Relations
沃爾格林-聯合博姿媒體關係
USA / Jim Cohn, +1 224 813 9057
美國/Jim Cohn，+1 224 813 9057
International, +44 (0)20 7980 8585
國際，+44 (0)20 7980 8585
WBA Investor Relations
沃爾格林-聯合博姿投資者關係
Tiffany Kanaga, +1 847 315 2922
Tiffany Kanaga，+1 847 315 2922
譯文內容由第三人軟體翻譯。